Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.
about
Influence of Study Design Variables on Clinical Pathology Data.Characterization, biomarkers, and reversibility of a monoclonal antibody-induced immune complex disease in cynomolgus monkeys (Macaca fascicularis).At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibodyComplement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and EpitheliumCR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Label-free detection of immune complexes with myeloid cells.Early Detection of Circulating Antigen and IgM-Associated Immune Complexes during Experimental Mycobacterium bovis Infection in Cattle.Interpreting and Integrating Clinical and Anatomic Pathology Results.Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific AntibodySEC Based Method for Size Determination of Immune Complexes of Therapeutic Antibodies in Animal Matrix.Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.Recombinant Proteins and Monoclonal Antibodies.Unexpected Toxicology Findings in Rats Dosed With an Antihuman IL-13 Monoclonal Antibody.Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.Checkpoint inhibitor-associated cutaneous small vessel vasculitis
P2860
Q31160507-2D34D801-9D36-4452-928F-CF66F9AC1335Q33413840-C88FCA06-912A-41DC-918C-391B65D19722Q36517187-74EE7C6B-59CD-42C0-94C7-C946390E6491Q36775281-716F382F-2CE4-4C25-B354-BBD4EF58C6CEQ37464006-3AE3AAB7-AA0D-4757-8A31-993D59316D05Q38365365-C701B8CF-F8B2-4E5C-9F07-59C85500F53DQ38365744-B364977E-E518-4733-B8A3-7DB8AA228319Q38787980-20B814A3-D68B-4036-8661-E496878B19D7Q38839557-EBACA009-2CC7-413B-90B6-46C2557FED27Q39159531-B376B84E-F06E-4F4D-8A0D-3B21C9CE59A9Q40366353-B4DA9BA9-8D7B-4077-A20B-9E054B3E2D6AQ42118088-7B3029D2-D9E8-46E2-B612-7F3264C16492Q46317826-F3D41441-1BF2-411F-85FE-0BF65989A079Q47602370-F2DAEAAE-ED39-4F47-A73F-C5A834689140Q48102317-E5826B0E-22FE-4D6E-A50D-AE2ADB36E8E1Q48138068-DB7D857F-4BF1-4643-B5E7-C7C9096B3007Q56890171-9329BBBB-69C4-4DAF-BF97-E761C3ED32E1
P2860
Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Formation, clearance, depositi ...... exes: review and case studies.
@en
type
label
Formation, clearance, depositi ...... exes: review and case studies.
@en
prefLabel
Formation, clearance, depositi ...... exes: review and case studies.
@en
P2093
P2860
P356
P1476
Formation, clearance, depositi ...... exes: review and case studies.
@en
P2093
Bruce Freimark
Christopher Horvath
Emanuel Schenck
Gary Waine
James T Raymond
Jennifer L Rojko
Jill Haynes
Mark DeWitte
Mark G Evans
P2860
P304
P356
10.1177/0192623314526475
P407
P577
2014-04-03T00:00:00Z